| Name | Title | Contact Details |
|---|
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD.
Syngenta Biotechnology Inc is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AmCyte Inc. is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Zija International is a Lindon, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.